Literature DB >> 20501755

A case-control study of body mass index and breast cancer risk in white and African-American women.

Paula Berstad1, Ralph J Coates, Leslie Bernstein, Suzanne G Folger, Kathleen E Malone, Polly A Marchbanks, Linda K Weiss, Jonathan M Liff, Jill A McDonald, Brian L Strom, Michael S Simon, Dennis Deapen, Michael F Press, Ronald T Burkman, Robert Spirtas, Giske Ursin.   

Abstract

OBJECTIVE: Large body size has been associated with decreased risk of breast cancer in premenopausal women but with increased risk in postmenopausal women. Limited information is available about African-American women and differences by estrogen and progesterone receptor status.
METHODS: We analyzed data from the Women's Contraceptive and Reproductive Experiences Study among 3,997 white and African-American breast cancer case patients diagnosed in 1994 to 1998 and 4,041 control participants ages 35 to 64 years. We calculated multivariate odds ratios (OR) as measures of relative risk of breast cancer associated with self-reported body mass index (BMI) at age 18 and 5 years before diagnosis (recent BMI).
RESULTS: Risk tended to decrease with increasing BMI at age 18 years in all women [OR(BMI > or = 25 kg/m(2) versus < 20 kg/m(2)) = 0.76; 95% confidence interval (CI), 0.63-0.90; P(trend) = 0.005] and with recent BMI in premenopausal women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 0.81; 95% CI, 0.61-1.06; P(trend) = 0.05), unmodified by race. Among postmenopausal white but not African-American women, there was an inverse relation between recent BMI and risk. High recent BMI was associated with increased risk of estrogen receptor- and progesterone receptor-positive tumors among postmenopausal African-American women (OR(BMI > or = 35 kg/m(2) versus < 25 kg/m(2)) = 1.83; 95% CI, 1.08-3.09; P(trend) = 0.03).
CONCLUSION: Among women at age 35 to 64 years, BMI at age 18 years is inversely associated with risk of breast cancer, but association with recent BMI varies by menopause status, race, and hormone receptor status. IMPACT: Our findings indicate that studies of BMI and breast cancer should consider breast cancer subtypes. Copyright 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20501755      PMCID: PMC2891096          DOI: 10.1158/1055-9965.EPI-10-0025

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  52 in total

1.  Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan.

Authors:  Motoki Iwasaki; Tetsuya Otani; Manami Inoue; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  Ann Epidemiol       Date:  2006-12-15       Impact factor: 3.797

2.  Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.

Authors:  Daikwon Han; Jing Nie; Matthew R Bonner; Susan E McCann; Paola Muti; Maurizio Trevisan; Farah A Ramirez-Marrero; Dominica Vito; Jo L Freudenheim
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

3.  Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.

Authors:  Reiko Suzuki; Tove Rylander-Rudqvist; Weimin Ye; Shigehira Saji; Alicja Wolk
Journal:  Int J Cancer       Date:  2006-10-01       Impact factor: 7.396

4.  Adult weight change and risk of postmenopausal breast cancer.

Authors:  A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

5.  Longitudinal study on the role of body size in premenopausal breast cancer.

Authors:  Karin B Michels; Kathryn L Terry; Walter C Willett
Journal:  Arch Intern Med       Date:  2006-11-27

6.  Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women.

Authors:  Martha L Slattery; Carol Sweeney; Sandra Edwards; Jennifer Herrick; Kathy Baumgartner; Roger Wolff; Maureen Murtaugh; Richard Baumgartner; Anna Giuliano; Tim Byers
Journal:  Breast Cancer Res Treat       Date:  2007-03       Impact factor: 4.872

7.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

8.  Does breast size modify the association between mammographic density and breast cancer risk?

Authors:  Anne Stuedal; Huiyan Ma; Leslie Bernstein; Malcolm C Pike; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

9.  A prospective study of body size and breast cancer in black women.

Authors:  Julie R Palmer; Lucile L Adams-Campbell; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 10.  Estrogens, progestins, and risk of breast cancer.

Authors:  M C Pike; A H Wu; D V Spicer; S Lee; C L Pearce
Journal:  Ernst Schering Found Symp Proc       Date:  2007
View more
  52 in total

Review 1.  Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.

Authors:  Elisa V Bandera; Gertraud Maskarinec; Isabelle Romieu; Esther M John
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

2.  African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy Rates.

Authors:  Anna H Wu; Celeste L Pearce; Chiu-Chen Tseng; Malcolm C Pike
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-14       Impact factor: 4.254

3.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

Review 4.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

5.  Body size in early life and breast cancer risk in African American and European American women.

Authors:  Elisa V Bandera; Urmila Chandran; Gary Zirpoli; Gregory Ciupak; Dana H Bovbjerg; Lina Jandorf; Karen Pawlish; Jo L Freudenheim; Christine B Ambrosone
Journal:  Cancer Causes Control       Date:  2013-10-10       Impact factor: 2.506

6.  High atherogenic index of plasma and cardiovascular risk factors among Ghanaian breast cancer patients.

Authors:  Emmanuel A Tagoe; Eric Dwamena-Akoto; Josephine Nsaful; Anastasia R Aikins; Joe-Nat Clegg-Lamptey; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

7.  Excess weight gain accelerates 1-methyl-1-nitrosourea-induced mammary carcinogenesis in a rat model of premenopausal breast cancer.

Authors:  Shawna B Matthews; Zongjian Zhu; Weiqin Jiang; John N McGinley; Elizabeth S Neil; Henry J Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-17

8.  Early-life factors and breast cancer risk in Hispanic women: the role of adolescent body size.

Authors:  Meera Sangaramoorthy; Amanda I Phipps; Pamela L Horn-Ross; Jocelyn Koo; Esther M John
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-04       Impact factor: 4.254

Review 9.  Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology.

Authors:  Eric C Dietze; Tanya A Chavez; Victoria L Seewaldt
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

Review 10.  Studying Adipose Tissue in the Breast Tumor Microenvironment In Vitro: Progress and Opportunities.

Authors:  David Mertz; Jason Sentosa; Gary Luker; Shuichi Takayama
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.